美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=CYCLOBENZAPRINE HYDROCHLORIDE"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
CYCLOBENZAPRINE HYDROCHLORIDE 206703 001 ANDA CYCLOBENZAPRINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 15MG No No 2018/07/24 2018/07/24 APOTEX Discontinued
CYCLOBENZAPRINE HYDROCHLORIDE 206703 002 ANDA CYCLOBENZAPRINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 30MG No No 2018/07/24 2018/07/24 APOTEX Discontinued
CYCLOBENZAPRINE HYDROCHLORIDE 213324 001 ANDA CYCLOBENZAPRINE HYDROCHLORIDE TABLET;ORAL 5MG No No 2020/07/06 2020/07/06 UNICHEM Prescription
CYCLOBENZAPRINE HYDROCHLORIDE 213324 002 ANDA CYCLOBENZAPRINE HYDROCHLORIDE TABLET;ORAL 7.5MG No No 2020/07/06 2020/07/06 UNICHEM Prescription
CYCLOBENZAPRINE HYDROCHLORIDE 213324 003 ANDA CYCLOBENZAPRINE HYDROCHLORIDE TABLET;ORAL 10MG No No 2020/07/06 2020/07/05 UNICHEM Prescription
CYCLOBENZAPRINE HYDROCHLORIDE 207314 001 ANDA CYCLOBENZAPRINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 15MG No No 2024/07/22 2024/07/22 MACLEODS PHARMS LTD Prescription
CYCLOBENZAPRINE HYDROCHLORIDE 207314 002 ANDA CYCLOBENZAPRINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 30MG No No 2024/07/22 2024/07/22 MACLEODS PHARMS LTD Prescription
CYCLOBENZAPRINE HYDROCHLORIDE 214732 001 ANDA CYCLOBENZAPRINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 15MG No No 2024/08/27 2024/08/27 NOVAST LABS Prescription
CYCLOBENZAPRINE HYDROCHLORIDE 214732 002 ANDA CYCLOBENZAPRINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 30MG No No 2024/08/27 2024/08/27 NOVAST LABS Prescription
CYCLOBENZAPRINE HYDROCHLORIDE 218936 001 ANDA CYCLOBENZAPRINE HYDROCHLORIDE TABLET;ORAL 5MG No No 2024/09/12 2024/09/12 GRAVITI PHARMS Prescription
CYCLOBENZAPRINE HYDROCHLORIDE 218936 002 ANDA CYCLOBENZAPRINE HYDROCHLORIDE TABLET;ORAL 7.5MG No No 2024/09/12 2024/09/12 GRAVITI PHARMS Prescription
CYCLOBENZAPRINE HYDROCHLORIDE 218936 003 ANDA CYCLOBENZAPRINE HYDROCHLORIDE TABLET;ORAL 10MG No No 2024/09/12 2024/09/12 GRAVITI PHARMS Prescription
药品名称,活性成分,申请号搜索 高级检索
©2006-2024 DrugFuture->U.S. FDA Drugs Database